Drug Discovery

Specialist Stem Cell Biotech Axol Bioscience Enhances Its Future Scientific and Commercial Endeavors
Notable private equity firm invests £2.5 million in the Cambridge-based biotech
| 1 min read

Scientists have created a new way of screening compounds that is more sensitive than existing methods, opening up the possibility of finding new drugs for many diseases
| 3 min read
















